These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 26273338)
1. Analysis for the mechanism between the small cell lung cancer and non-small cell lung cancer combing the miRNA and mRNA expression profiles. Zhang W; Zhang Q; Zhang M; Zhang Y; Li F; Lei P Thorac Cancer; 2015 Jan; 6(1):70-9. PubMed ID: 26273338 [TBL] [Abstract][Full Text] [Related]
2. Network analysis in the identification of special mechanisms between small cell lung cancer and non-small cell lung cancer. Zhang W; Zhang Q; Zhang M; Zhang Y; Li F; Lei P Thorac Cancer; 2014 Nov; 5(6):556-64. PubMed ID: 26767052 [TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173 [TBL] [Abstract][Full Text] [Related]
4. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer. Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086 [TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer. Yang C; Sun C; Liang X; Xie S; Huang J; Li D Cancer Gene Ther; 2016 Apr; 23(4):90-7. PubMed ID: 26964645 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines. Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600 [TBL] [Abstract][Full Text] [Related]
7. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis. Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238 [TBL] [Abstract][Full Text] [Related]
8. Mining featured micro ribonucleic acids associated with lung cancer based on bioinformatics. Su L; Li N; Huo X Thorac Cancer; 2015 Jul; 6(4):501-7. PubMed ID: 26273407 [TBL] [Abstract][Full Text] [Related]
9. miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro. Miao Y; Li J; Qiu X; Li Y; Wang Z; Luan Y Oncol Rep; 2013 Jan; 29(1):161-8. PubMed ID: 23117485 [TBL] [Abstract][Full Text] [Related]
10. Expression of placental growth factor gene in lung cancer. Woo IS; Park MJ; Byun JH; Hong YS; Lee KS; Park YS; Lee JA; Park YI; Ahn HK Tumour Biol; 2004; 25(1-2):1-6. PubMed ID: 15192305 [TBL] [Abstract][Full Text] [Related]
11. Identification of microRNA differentially expressed in three subtypes of non-small cell lung cancer and in silico functional analysis. Hu Y; Wang L; Gu J; Qu K; Wang Y Oncotarget; 2017 Sep; 8(43):74554-74566. PubMed ID: 29088807 [TBL] [Abstract][Full Text] [Related]
12. Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer. Fang S; Zeng X; Zhu W; Tang R; Chao Y; Guo L Exp Mol Pathol; 2014 Jun; 96(3):438-44. PubMed ID: 24769353 [TBL] [Abstract][Full Text] [Related]
13. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway. Liu M; Zhou K; Huang Y; Cao Y J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667 [TBL] [Abstract][Full Text] [Related]
15. miRNA-mRNA interaction network in non-small-cell lung cancer. Ma R; Wang C; Wang J; Wang D; Xu J Interdiscip Sci; 2015 Apr; ():. PubMed ID: 25863966 [TBL] [Abstract][Full Text] [Related]
16. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer. Najafi A; Tavallaei M; Hosseini SM Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675 [TBL] [Abstract][Full Text] [Related]
18. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer. Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Patnaik SK; Kannisto E; Knudsen S; Yendamuri S Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression profiling of sputum for the detection of early and locally advanced non-small-cell lung cancer: a prospective case-control study. Razzak R; Bédard EL; Kim JO; Gazala S; Guo L; Ghosh S; Joy A; Nijjar T; Wong E; Roa WH Curr Oncol; 2016 Apr; 23(2):e86-94. PubMed ID: 27122989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]